Hu J - Search Results

1

Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells.

Huang F, Zhang Q, Xiao J, Zhang X, Han X, Shi X, Hu J, Li L, Qian X. Huang F, et al. Among authors: hu j. Int J Nanomedicine. 2023 May 2;18:2261-2273. doi: 10.2147/IJN.S408521. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37159807 Free PMC article.

2

[Inhibitory effect of oxaliplatin in combination with hyperthermia on angiogenesis].

Qian XP, Liu BR, Li M, Hu J, Hu WJ, Zou ZY, Wang LF, Yu LX. Qian XP, et al. Among authors: hu j, hu wj. Zhonghua Zhong Liu Za Zhi. 2007 Nov;29(11):826-9. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 18396639 Chinese.

3

[Inhibitory effect of tetrandrine on angiogenesis].

Qian XP, Liu BR, Hu J, Li M, Hu WJ, Sun J, Yu LX. Qian XP, et al. Among authors: hu j, hu wj. Ai Zheng. 2008 Oct;27(10):1050-5. Ai Zheng. 2008. PMID: 18851784 Free article. Chinese.

4

[Anti-angiogenic effect of vinorelbine in combination with cetuximab in vitro and in vivo].

Qian XP, Liu BR, Wan L, Hu J, Zhu LJ, Yu LX. Qian XP, et al. Among authors: hu j. Zhonghua Zhong Liu Za Zhi. 2010 Apr;32(4):253-7. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20510073 Chinese.

5

[Relationship between BRCA1 mRNA expression in tumor cells from malignant effusions and chemosensitivity to cisplatin in patients with metastatic malignant effusions].

Qian XP, Liu BR, Jiang M, Hu J, Yu LX, Wang LF, Hu WJ, Zou ZY. Qian XP, et al. Among authors: hu j, hu wj. Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):457-60. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875488 Chinese.

6

Rhizoma Paridis ethanol extract selectively inhibits the proliferation of HUVECs comparing to Lovo cells and shows anti-angiogenesis effects in a mouse model.

Qian X, Zhu L, Hu J, Li M, Xie L, Wang L, Yu L, Liu B. Qian X, et al. Among authors: hu j. J Ethnopharmacol. 2012 Aug 30;143(1):256-61. doi: 10.1016/j.jep.2012.06.032. Epub 2012 Jun 28. J Ethnopharmacol. 2012. PMID: 22750432

7

TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer.

Zhang Q, Shen J, Wang H, Hu J, Yu L, Xie L, Wei J, Liu B, Guan W, Qian X. Zhang Q, et al. Among authors: hu j. Cancer Chemother Pharmacol. 2014 Feb;73(2):325-33. doi: 10.1007/s00280-013-2354-z. Epub 2013 Nov 27. Cancer Chemother Pharmacol. 2014. PMID: 24281197

8

UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians.

Cheng L, Li M, Hu J, Ren W, Xie L, Sun ZP, Liu BR, Xu GX, Dong XL, Qian XP. Cheng L, et al. Among authors: hu j. Cancer Chemother Pharmacol. 2014 Mar;73(3):551-60. doi: 10.1007/s00280-014-2382-3. Epub 2014 Jan 22. Cancer Chemother Pharmacol. 2014. PMID: 24448639 Review.

9

Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories.

Cheng L, Ren W, Xie L, Li M, Liu J, Hu J, Liu BR, Qian XP. Cheng L, et al. Among authors: hu j. Cancer Chemother Pharmacol. 2014 Jul;74(1):1-13. doi: 10.1007/s00280-014-2489-6. Epub 2014 Jun 11. Cancer Chemother Pharmacol. 2014. PMID: 24916545 Review.

10

Enhancement of Radiation Effects by Ursolic Acid in BGC-823 Human Adenocarcinoma Gastric Cancer Cell Line.

Yang Y, Jiang M, Hu J, Lv X, Yu L, Qian X, Liu B. Yang Y, et al. Among authors: hu j. PLoS One. 2015 Jul 15;10(7):e0133169. doi: 10.1371/journal.pone.0133169. eCollection 2015. PLoS One. 2015. PMID: 26177078 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,668 results

Search Page

Filters